Levosimendan as Rescue Therapy for Acute Heart Failure in a Patient with Duchenne Muscular Dystrophy

被引：7
|
作者：
Sumanaru, Dorin [1 ]
Josseran, Loic [2 ,3 ]
Essid, Aben [1 ]
Mbieleu, Blaise [1 ]
Haegy, Isabelle [1 ]
Bergounioux, Jean [1 ,2 ,4 ]
机构：
[1] Hop Raymond Poincare, AP HP, Pediat Intens Care Unit, F-92380 Garches, France
[2] Hop Raymond Poincare, AP HP, Epidemiol Dept, F-92380 Garches, France
[3] Versailles St Quentin Yvelines Univ, Versailles, France
[4] Hop Raymond Poincare, AP HP, Reanimat & Soins Intensifs Pediat, 104 Blvd Raymond Poincare, F-92380 Garches, France
来源：
PEDIATRIC CARDIOLOGY | 2019年 / 40卷 / 03期
关键词：
Duchenne muscular dystrophy; Levosimendan; Acute heart failure; ARRHYTHMIAS; SAFETY;
D O I：
10.1007/s00246-019-02072-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The longer survival of patients with Duchenne muscular dystrophy due to advances in clinical care has increased the incidence of Duchenne muscular dystrophy-associated cardiomyopathy, a nearly consistent feature in the third decade of life. A 26-year-old patient with Duchenne muscular dystrophy experienced severe acute heart failure triggered by pneumonia. Levosimendan was effective in improving heart function.
引用
收藏
页码：668 / 670
页数：3
相关论文
共 50 条
  • [41] Prophylactic oral bisphosphonate therapy in duchenne muscular dystrophy
    Srinivasan, Ramesh
    Rawlings, David
    Wood, Claire L.
    Cheetham, Tim
    Moreno, Aura Cecilia Jimenez
    Mayhew, Anna
    Eagle, Michelle
    Guglieri, Michela
    Straub, Volker
    Owen, Catherine
    Bushby, Kate
    Sarkozy, Anna
    MUSCLE & NERVE, 2016, 54 (01) : 79 - 85
  • [42] Steroid therapy and cardiac function in Duchenne muscular dystrophy
    Markham, LW
    Spicer, RL
    Khoury, PR
    Wong, BL
    Mathews, KD
    Cripe, LH
    PEDIATRIC CARDIOLOGY, 2005, 26 (06) : 768 - 771
  • [43] Problems and potential for gene therapy in Duchenne muscular dystrophy
    Kakulas, BA
    NEUROMUSCULAR DISORDERS, 1997, 7 (05) : 319 - 324
  • [44] The role of utrophin in the potential therapy of Duchenne muscular dystrophy
    Perkins, KJ
    Davies, KE
    NEUROMUSCULAR DISORDERS, 2002, 12 : S78 - S89
  • [45] Diagnosis and therapy of Duchenne and Becker forms of muscular dystrophy
    Kirschner, J.
    MEDIZINISCHE GENETIK, 2009, 21 (03) : 322 - 326
  • [46] Perspectives of stem cell therapy in Duchenne muscular dystrophy
    Meregalli, Mirella
    Farini, Andrea
    Belicchi, Marzia
    Parolini, Daniele
    Cassinelli, Letizia
    Razini, Paola
    Sitzia, Clementina
    Torrente, Yvan
    FEBS JOURNAL, 2013, 280 (17) : 4251 - 4262
  • [47] Progress in gene therapy for Duchenne muscular dystrophy.
    Clemens P.R.
    Duncan F.J.
    Current Neurology and Neuroscience Reports, 2001, 1 (1) : 89 - 96
  • [48] Treatment of Acute Heart Failure Using Levosimendan for a Patient With Dilated Cardiomyopathy, Chronic Renal Failure, and Hypertension
    Pablo Lobo Martínez
    Ignacio Oulego Erroz
    Sandra Gautreux Minaya
    Luis Miguel Rodríguez Fernández
    Pediatric Cardiology, 2011, 32
  • [49] Gene therapy progress and prospects: Duchenne muscular dystrophy
    Foster, K.
    Foster, H.
    Dickson, J. G.
    GENE THERAPY, 2006, 13 (24) : 1677 - 1685
  • [50] Genetic correction strategies for Duchenne muscular dystrophy and their impact on the heart
    Johnston, Jamie R.
    McNally, Elizabeth M.
    PROGRESS IN PEDIATRIC CARDIOLOGY, 2021, 63
12345